Skip to main content
. 2022 Jan 12;8(2):eabi8683. doi: 10.1126/sciadv.abi8683

Fig. 6. Appropriate inhibition of adult angiogenesis extended the reproductive life span of aged females.

Fig. 6.

(A) The strategy of Axi treatment in females of late reproductive life span. After 1 month of Axi or vehicle treatment, females at 8 months were mated to check their fertility and were used to detect other reproductive-related indices at different time points. (B) Histological analysis showing Axi-treated ovaries exhibited a clear younger status at 14 months with many follicles (arrows) compared with the control ovaries. (C) Follicle counting results showing that more follicles survived in the Axi-treated ovaries compared with the controls at the age of 14 months (n = 6). (D) Fertility test results showed a significant extension of the female reproductive life span after Axi treatment (n = 21). (E and F) The sex-related hormones, including follicle-stimulating hormone (FSH) and estrogen (E2), were found to be comparable in untreated females at 8 months and Axi-treated females at 14 months of age, whereas significantly increased levels of FSH and decreased levels of E2 were detected in the 14-month-old females of the DMSO group (n = 8 per group). (G) The general appearance of Axi-treated and the control females at 14 months, showing healthy pups with Axi-treated mothers (Photo credit: Xueqiang Xu, China Agricultural University). The data are presented as means ± SD. The data were analyzed by a two-tailed unpaired Student’s t test; ***P < 0.001, **P < 0.01, n.s. P ≥ 0.05. Scale bars, 100 μm (B).